< back to main site

Publications

Items where Author is "Prise, K M*"

Group by: Item Type | No Grouping
Jump to: Article
Number of items: 8.

Article

Rosa, S*; Connolly, C; Schettino, G; Butterworth, K T*; Prise, K M* (2017) Biological mechanisms of gold nanoparticle radiosensitization. Cancer Nanotechnol., 8 (1). p. 2.

Acheva, A*; Schettino, G; Prise, K M* (2017) Pro-inflammatory signaling in a 3 D organotypic skin model after low LET irradiation-NF-kappa B, COX-2 activation and impact on cell differentiation. Frontiers in Immunology, 8. p. 82.

McQuaid, H N*; Muir, M F*; Taggert, L E*; McMahon, S J*; Coulter, J A*; Hyland, W B*; Jain, S*; Butterworth, K T*; Schettino, G; Prise, K M*; Hirst, D G*; Botchway, S W*; Currell, F J* (2016) Imaging and radiation effects of gold nanoparticles in tumour cells. Sci. Rep., 6. p. 19442.

Ghita, M*; Coffey, C B*; Butterworth, K T*; McMahon, S J*; Schettino, G; Prise, K M* (2016) Impact of fractionation on out-of-field survival and DNA damage responses following exposure to intensity modulated radiation fields. Phys. Med. Biol., 61 (2). pp. 515-526.

Marshall, T I*; Chaudhary, P*; Michaelidesova, A*; Vechelova, J*; Davidkova, M*; Vondracek, V*; Schettino, G; Prise, K M* (2016) Investigating the implications of a variable RBE on proton dose fractionation across a clinical pencil beam scanned spread-out Bragg peak. Int. J. Radiat. Oncol. Biol. Phys., 95 (1). pp. 70-77.

Chaudhary, P*; Marshall, T I*; Currell, F J*; Kacperek, A*; Schettino, G; Prise, K M* (2016) Variations in the processing of DNA double-strand breaks along 60 MeV therapeutic proton beams. Int. J. Radiat. Oncol. Biol. Phys., 95 (1). pp. 86-94.

Acheva, A*; Ghita, M*; Patel, G*; Prise, K M*; Schettino, G (2014) Mechanisms of DNA damage response to targeted irradiation in organotypic 3D skin cultures. PLOS One, 9 (2). p. 86092.

Chaudhary, P*; Marshall, T I*; Perozziello, F M*; Manti, L*; Currell, F J*; Hanton, F*; McMahon, S J*; Kavanagh, J N*; Cirrone, G A P*; Romano, F*; Prise, K M*; Schettino, G (2014) Relative biological effectiveness variation along monoenergetic and modulated Bragg peaks of a 62-MeV therapeutic proton beam: a preclinical assessment. Int. J. Radiat. Oncol. Biol. Phys., 90 (1). pp. 27-35.

This list was generated on Wed Oct 29 10:39:09 2025 GMT.